TransMedics Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade TransMedics Group 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TMDX

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. 

CEO
Waleed H. Hassanein
CEOWaleed H. Hassanein
Employees
898
Employees898
Headquarters
Andover, Massachusetts
HeadquartersAndover, Massachusetts
Founded
1998
Founded1998
Employees
898
Employees898

TMDX Key Statistics

Market cap
4.62B
Market cap4.62B
Price-Earnings ratio
26.59
Price-Earnings ratio26.59
Dividend yield
Dividend yield
Average volume
1.23M
Average volume1.23M
High today
$135.28
High today$135.28
Low today
$122.38
Low today$122.38
Open price
$125.25
Open price$125.25
Volume
1.16M
Volume1.16M
52 Week high
$156.00
52 Week high$156.00
52 Week low
$62.23
52 Week low$62.23

Stock Snapshot

TransMedics Group(TMDX) stock is priced at $134.60, giving the company a market capitalization of 4.62B. It carries a P/E multiple of 26.59.

On 2026-03-10, TransMedics Group(TMDX) stock traded between a low of $122.38 and a high of $135.28. Shares are currently priced at $134.60, which is +10.0% above the low and -0.5% below the high.

The TransMedics Group(TMDX)'s current trading volume is 1.16M, compared to an average daily volume of 1.23M.

In the last year, TransMedics Group(TMDX) shares hit a 52-week high of $156.00 and a 52-week low of $62.23.

In the last year, TransMedics Group(TMDX) shares hit a 52-week high of $156.00 and a 52-week low of $62.23.

TMDX News

Nasdaq 2d
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026?

Key Points TransMedics remains the top dog in its industry and may have a widening moat. The founder-led company's shares have risen eightfold since 2019. Tr...

TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026?
Simply Wall St 5d
A Look At TransMedics Group Valuation After Strong Results And Optimistic Revenue Guidance

TransMedics Group (TMDX) is back in focus after reporting fourth quarter and full year 2025 results, with higher revenue and earnings, and releasing 2026 revenu...

A Look At TransMedics Group Valuation After Strong Results And Optimistic Revenue Guidance

Analyst ratings

75%

of 12 ratings
Buy
75%
Hold
25%
Sell
0%

People also own

Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.